Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 23247234)

1.

Predicting HPV status in head and neck cancer: the predictive value of sociodemographic and disease characteristics.

Byrd JK, Wilhoit CS, Fordham MT, Reeves TD, McRackan TR, Nguyen SA, Sutkowski N, Gillespie MB.

Arch Otolaryngol Head Neck Surg. 2012 Dec;138(12):1155-9. doi: 10.1001/jamaoto.2013.850. Erratum in: Arch Otolaryngol Head Neck Surg. 2013 Apr;139(4):339. McCrackan, Theodore R [corrected to McRackan, Theodore R].

PMID:
23247234
3.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

4.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

5.

The benefit of early PET/CT surveillance in HPV-associated head and neck squamous cell carcinoma.

Zhang I, Branstetter BF 4th, Beswick DM, Maxwell JH, Gooding WE, Ferris RL.

Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1106-11. doi: 10.1001/archoto.2011.181.

PMID:
22106234
6.

A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.

Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB.

Mod Pathol. 2011 Oct;24(10):1295-305. doi: 10.1038/modpathol.2011.91. Epub 2011 May 13.

7.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
8.

Role of cytology in the diagnosis and management of HPV-associated head and neck carcinoma.

Krane JF.

Acta Cytol. 2013;57(2):117-26. doi: 10.1159/000346715. Epub 2013 Feb 28. Review.

9.

Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus.

Mehrad M, Carpenter DH, Chernock RD, Wang H, Ma XJ, Luo Y, Luo J, Lewis JS Jr, El-Mofty SK.

Am J Surg Pathol. 2013 Sep;37(9):1349-56. doi: 10.1097/PAS.0b013e318290427d.

10.

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R.

J Natl Cancer Inst. 2008 Mar 19;100(6):407-20. doi: 10.1093/jnci/djn025. Epub 2008 Mar 11.

12.

Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma.

Donà MG, Giuliani M, Vocaturo A, Spriano G, Pichi B, Rollo F, Ronchetti L, Covello R, Pescarmona E, Benevolo M.

Cancer. 2014 Nov 15;120(22):3477-84. doi: 10.1002/cncr.28909. Epub 2014 Jul 9.

PMID:
25043660
13.

Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status.

Bishop JA, Maleki Z, Valsamakis A, Ogawa T, Chang X, Pai SI, Westra WH.

Cancer Cytopathol. 2012 Feb 25;120(1):18-25. doi: 10.1002/cncy.20175. Epub 2011 Jul 12.

14.
15.

Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer.

D'Souza G, Zhang HH, D'Souza WD, Meyer RR, Gillison ML.

Oral Oncol. 2010 Feb;46(2):100-4. doi: 10.1016/j.oraloncology.2009.11.004. Epub 2009 Dec 29.

16.

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI.

Laryngoscope. 2009 Aug;119(8):1542-9. doi: 10.1002/lary.20533.

PMID:
19522004
17.

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML.

J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12.

18.

Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.

Gudleviciene Z, Smailyte G, Mickonas A, Pikelis A.

Oncology. 2009;76(3):205-8. doi: 10.1159/000201573. Epub 2009 Feb 11.

PMID:
19209011
19.

Spindle cell carcinomas of the head and neck rarely harbor transcriptionally-active human papillomavirus.

Watson RF, Chernock RD, Wang X, Liu W, Ma XJ, Luo Y, Wang H, El-Mofty SK, Lewis JS Jr.

Head Neck Pathol. 2013 Sep;7(3):250-7. doi: 10.1007/s12105-013-0438-z. Epub 2013 Mar 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk